Serum sickness following a first rituximab infusion with no recurrence after the second one.
Mehsen
N
N
Yvon
C-M
CM
Richez
C
C
Schaeverbeke
T
T
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects*; D007262:Infusions, Intravenous; D008947:Mixed Connective Tissue Disease / Q000188:drug therapy* / Q000276:immunology; D000069283:Rituximab; D012713:Serum Sickness / Q000139:chemically induced* / Q000276:immunology; D055815:Young Adult
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab